TY - JOUR
T1 - Bi-allelic ATG4D variants are associated with a neurodevelopmental disorder characterized by speech and motor impairment
AU - Undiagnosed Diseases Network
AU - Morimoto, Marie
AU - Bhambhani, Vikas
AU - Gazzaz, Nour
AU - Davids, Mariska
AU - Sathiyaseelan, Paalini
AU - Macnamara, Ellen F.
AU - Lange, Jennifer
AU - Lehman, Anna
AU - Zerfas, Patricia M.
AU - Murphy, Jennifer L.
AU - Acosta, Maria T.
AU - Wang, Camille
AU - Alderman, Emily
AU - Adam, Margaret
AU - Alvarez, Raquel L.
AU - Alvey, Justin
AU - Amendola, Laura
AU - Andrews, Ashley
AU - Ashley, Euan A.
AU - Azamian, Mahshid S.
AU - Bacino, Carlos A.
AU - Bademci, Guney
AU - Balasubramanyam, Ashok
AU - Baldridge, Dustin
AU - Bale, Jim
AU - Bamshad, Michael
AU - Barbouth, Deborah
AU - Bayrak-Toydemir, Pinar
AU - Beck, Anita
AU - Beggs, Alan H.
AU - Behrens, Edward
AU - Bejerano, Gill
AU - Bellen, Hugo J.
AU - Bennett, Jimmy
AU - Berg-Rood, Beverly
AU - Bernstein, Jonathan A.
AU - Berry, Gerard T.
AU - Bican, Anna
AU - Bivona, Stephanie
AU - Blue, Elizabeth
AU - Bohnsack, John
AU - Bonner, Devon
AU - Botto, Lorenzo
AU - Boyd, Brenna
AU - Briere, Lauren C.
AU - Dasari, Surendra
AU - Lanpher, Brendan C.
AU - Lanza, Ian R.
AU - Morava-Kozicz, Eva
AU - Oglesbee, Devin
N1 - Funding Information:
The authors thank all the patients and their families for their participation in this study. The authors thank Drs. Virginie Betin and Jon D. Lane (University of Bristol, United Kingdom) for helpful discussions and sharing their technical expertise on the protein purification and in vitro GABARAPL1 priming assay as well as Drs. Thanh Ngoc Nguyen and Michael Lazarou (Biomedicine Discovery Institute, Monash University, Melbourne, Australia) for sharing the ATG4 tetra knockout and ATG5 knockout cell lines. This study was supported in part by the Canadian Institutes of Health (CIHR) (operating grant MOP-78882 to SMG), the National Human Genome Research Institute (NHGRI) Intramural Research Program, and the National Institutes of Health (NIH) Common Fund from the Office of the Director.
Funding Information:
Open Access funding provided by the National Institutes of Health (NIH).
Funding Information:
The authors thank all the patients and their families for their participation in this study. The authors thank Drs. Virginie Betin and Jon D. Lane (University of Bristol, United Kingdom) for helpful discussions and sharing their technical expertise on the protein purification and in vitro GABARAPL1 priming assay as well as Drs. Thanh Ngoc Nguyen and Michael Lazarou (Biomedicine Discovery Institute, Monash University, Melbourne, Australia) for sharing the ATG4 tetra knockout and ATG5 knockout cell lines. This study was supported in part by the Canadian Institutes of Health (CIHR) (operating grant MOP-78882 to SMG), the National Human Genome Research Institute (NHGRI) Intramural Research Program, and the National Institutes of Health (NIH) Common Fund from the Office of the Director.
Publisher Copyright:
© 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
PY - 2023/12
Y1 - 2023/12
N2 - Autophagy regulates the degradation of damaged organelles and protein aggregates, and is critical for neuronal development, homeostasis, and maintenance, yet few neurodevelopmental disorders have been associated with pathogenic variants in genes encoding autophagy-related proteins. We report three individuals from two unrelated families with a neurodevelopmental disorder characterized by speech and motor impairment, and similar facial characteristics. Rare, conserved, bi-allelic variants were identified in ATG4D, encoding one of four ATG4 cysteine proteases important for autophagosome biogenesis, a hallmark of autophagy. Autophagosome biogenesis and induction of autophagy were intact in cells from affected individuals. However, studies evaluating the predominant substrate of ATG4D, GABARAPL1, demonstrated that three of the four ATG4D patient variants functionally impair ATG4D activity. GABARAPL1 is cleaved or “primed” by ATG4D and an in vitro GABARAPL1 priming assay revealed decreased priming activity for three of the four ATG4D variants. Furthermore, a rescue experiment performed in an ATG4 tetra knockout cell line, in which all four ATG4 isoforms were knocked out by gene editing, showed decreased GABARAPL1 priming activity for the two ATG4D missense variants located in the cysteine protease domain required for priming, suggesting that these variants impair the function of ATG4D. The clinical, bioinformatic, and functional data suggest that bi-allelic loss-of-function variants in ATG4D contribute to the pathogenesis of this syndromic neurodevelopmental disorder.
AB - Autophagy regulates the degradation of damaged organelles and protein aggregates, and is critical for neuronal development, homeostasis, and maintenance, yet few neurodevelopmental disorders have been associated with pathogenic variants in genes encoding autophagy-related proteins. We report three individuals from two unrelated families with a neurodevelopmental disorder characterized by speech and motor impairment, and similar facial characteristics. Rare, conserved, bi-allelic variants were identified in ATG4D, encoding one of four ATG4 cysteine proteases important for autophagosome biogenesis, a hallmark of autophagy. Autophagosome biogenesis and induction of autophagy were intact in cells from affected individuals. However, studies evaluating the predominant substrate of ATG4D, GABARAPL1, demonstrated that three of the four ATG4D patient variants functionally impair ATG4D activity. GABARAPL1 is cleaved or “primed” by ATG4D and an in vitro GABARAPL1 priming assay revealed decreased priming activity for three of the four ATG4D variants. Furthermore, a rescue experiment performed in an ATG4 tetra knockout cell line, in which all four ATG4 isoforms were knocked out by gene editing, showed decreased GABARAPL1 priming activity for the two ATG4D missense variants located in the cysteine protease domain required for priming, suggesting that these variants impair the function of ATG4D. The clinical, bioinformatic, and functional data suggest that bi-allelic loss-of-function variants in ATG4D contribute to the pathogenesis of this syndromic neurodevelopmental disorder.
UR - http://www.scopus.com/inward/record.url?scp=85148304996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148304996&partnerID=8YFLogxK
U2 - 10.1038/s41525-022-00343-8
DO - 10.1038/s41525-022-00343-8
M3 - Article
AN - SCOPUS:85148304996
SN - 2056-7944
VL - 8
JO - npj Genomic Medicine
JF - npj Genomic Medicine
IS - 1
M1 - 4
ER -